Business Context and Reporting Period
This Form 6-K is filed by Prana Biotechnology Limited (not Altery Therapeutics Ltd as indicated in metadata) for the period ending September 28, 2006. The registrant is a foreign private issuer based in South Melbourne, Victoria, Australia, and files annual reports on Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural announcement regarding a new issue and does not contain financial statements.
Material Changes
The filing announces a New Issue, an application for quotation of additional securities, and an associated agreement. No comparative financial data or material changes to prior periods are disclosed in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, contingencies, or discussion of unusual items. The document is limited to the formal announcement of the securities transaction and the signature of the Executive Chairman, Geoffrey Kempler.
Key Facts for Investor Verification
- Verify the specific terms of the "New Issue" and "agreement" referenced in Item 1, as details are not included in this summary filing.
- Confirm the identity of the registrant as Prana Biotechnology Limited, noting the discrepancy with the metadata name "Altery Therapeutics Ltd."
- Check subsequent filings for the financial impact of the additional securities issuance.